
Michael E Ming MD
Dermatopathology
Associate Professor, Dermatology, Perelman School of Medicine
Join to View Full Profile
3400 Spruce Street2 Rhoads PavilionPhiladelphia, PA 19104
Phone+1 215-662-2737
Fax+1 215-349-8339
Dr. Ming is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of California (San Francisco)Fellowship, Dermatopathology, 1997 - 1999
- Mass General Brigham/Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 1994 - 1997
- Mass General Brigham/Massachusetts General HospitalInternship, Internal Medicine, 1993 - 1994
- Harvard Medical SchoolClass of 1993
Certifications & Licensure
- CA State Medical License 1997 - Present
- PA State Medical License 2000 - 2026
- American Board of Dermatology Dermatology
- American Board of Dermatology Dermatopathology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Tailored Intervention for Melanoma Patient's Families Start of enrollment: 2005 Aug 01
Publications & Presentations
PubMed
- Significance of Prognostic Factors across Tumor Thicknesses in Melanoma: A National Cohort Study.Kevin Ma, Neha Shafique, Gabriella Tortorello, Anushka Dheer, Luke J Keele
The Journal of Investigative Dermatology. 2025-03-12 - Impact of 8th edition American Joint Committee on Cancer staging changes on sentinel lymph node biopsy practices in melanoma.Gabriella N Tortorello, Neha Shafique, Anushka Dheer, Emily Y Chu, Michael E Ming
Journal of the American Academy of Dermatology. 2025-03-01 - Development of a treatment decision aid for patients with dysplastic nevi who are candidates for re-excision.Jaclyn N Roland-McGowan, Steven Caleb Freeman, Wenelia Baghoomian, Bryan T Carroll, Caroline Choi Kim
Journal of the American Academy of Dermatology. 2025-01-17
Journal Articles
- Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but with Positive Histologic MarginsDouglas Grossman, Vijay Balakrishnan, Laura K Ferris, Geoffrey Lim, Suephy C Chen, Meera Brahmbhatt, Susan M Swetter, Emily Y Chu, Nathaniel Fleming, Caroline C Kim, M..., JAMA
- Timing of Onset of Adverse Cutaneous Reactions Associated with Programmed Cell Death Protein 1 Inhibitor TherapyTara C Mitchell, Michael E Ming, Leo L Wang, Suzanne McGettigan, Emily Y Chu, Lynn Schuchter, JAMA
Press Mentions
- Guidance on the Clinical Understanding and Use of Long‐Acting Injectable Antipsychotics in Schizophrenia: Hong Kong Consensus StatementsFebruary 8th, 2021
- Cancer Patients May Experience Delayed Skin Effects of Anti-PD-1 TherapyJuly 18th, 2018
- Management Strategies of Academic Pigmented Lesion Clinic Directors in the United StatesJanuary 4th, 2018
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: